Canada okays 'liberation therapy' trials

June 29, 2011

Canada will fund clinical trials for a controversial multiple sclerosis treatment that targets blocked neck veins, Health Minister Leona Aglukkaq announced Wednesday.

"Patients and their families have been calling for funding of a clinical trial on a treatment to unblock veins," the minister said in the foyer of the House of Commons.

"Our government had been clear that we are prepared to fund a clinical trial but only when there was sufficient medical to support proceeding safely."

She said a scientific working group established by the government last August recommended proceeding with the trials after reviewing seven ongoing studies looking at "chronic cerebrospinal venous insufficiency" and its link to MS.

The Canadian Institute of Health Research plans to establish terms for the clinical trial. Afterward, the government will launch a call for applications to conduct the trials.

MS is an autoimmune disease that affects the brain and spinal cord, impairing vision and speech and muscle control, leading to tremors, spasms and chronic pain.

Italian researcher Paolo Zamboni theorized in 2008 that it could be reversed by unblocking neck veins using .

According to his theory, malformed blood vessels caused increased iron deposits in the brain that triggered the .

Many Canadian have sought the so-called "liberation treatment" abroad, as it is not offered in Canada. Some reported vast improvements in their mobility while others experienced little or no alleviation of symptoms.

Related Stories

Recommended for you

Study links small RNA molecule to pregnancy complication

October 24, 2016

A family of small RNA molecules affects the development of cells that give rise to the placenta - an organ that transfers oxygen and nutrients from mother to fetus—in ways that could contribute to a serious pregnancy complication, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.